These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3293092)

  • 21. Naloxone administration to patients with acute stroke.
    Jabaily J; Davis JN
    Stroke; 1984; 15(1):36-9. PubMed ID: 6364463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose intravenous naloxone for the treatment of acute ischemic stroke.
    Olinger CP; Adams HP; Brott TG; Biller J; Barsan WG; Toffol GJ; Eberle RW; Marler JR
    Stroke; 1990 May; 21(5):721-5. PubMed ID: 2339451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone and mortality in the gerbil stroke model.
    Benzel EC; Musgrove CC; Kesterson L
    South Med J; 1989 May; 82(5):555-7. PubMed ID: 2717980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind trial of naloxone in central post-stroke pain.
    Bainton T; Fox M; Bowsher D; Wells C
    Pain; 1992 Feb; 48(2):159-162. PubMed ID: 1589232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival.
    Baskin DS; Hosobuchi Y; Grevel JC
    J Neurosurg; 1986 Jan; 64(1):99-103. PubMed ID: 3941353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of naloxone to reverse vascular neurologic deficits.
    Cutler JR; Bredesen DE; Edwards R; Simon RP
    Neurology; 1983 Nov; 33(11):1517-8. PubMed ID: 6685246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
    Kurland AA; McCabe OL; Hanlon TE; Sullivan D
    Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind randomised trial of intravenous glycerol in acute stroke.
    Bayer AJ; Pathy MS; Newcombe R
    Lancet; 1987 Feb; 1(8530):405-8. PubMed ID: 2880214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycerol and dextran combined in the therapy of acute stroke. A placebo-controlled, double-blind trial with a planned interim analysis.
    Frei A; Cottier C; Wunderlich P; Lüdin E
    Stroke; 1987; 18(2):373-9. PubMed ID: 2436359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone in acute stroke.
    Mulley G; Wilcox RG; Mitchell JR
    Br Med J; 1978 Oct; 2(6143):994-6. PubMed ID: 361156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.
    Hsu CY; Faught RE; Furlan AJ; Coull BM; Huang DC; Hogan EL; Linet OI; Yatsu FM
    Stroke; 1987; 18(2):352-8. PubMed ID: 3551212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized double-blind controlled trial of naftidrofuryl in acute stroke.
    Gray CS; French JM; Venables GS; Cartlidge NE; James OF; Bates D
    Age Ageing; 1990 Nov; 19(6):356-63. PubMed ID: 2285001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.
    Duke RJ; Bloch RF; Turpie AG; Trebilcock R; Bayer N
    Ann Intern Med; 1986 Dec; 105(6):825-8. PubMed ID: 3535601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone in tardive dyskinesia.
    Blum I; Nisipeanu PF; Roberts E
    Psychopharmacology (Berl); 1987; 93(4):538. PubMed ID: 3124188
    [No Abstract]   [Full Text] [Related]  

  • 36. Methysergide (Sansert) treatment in acute stroke. Community pilot study.
    Weintraub MI
    Angiology; 1985 Mar; 36(3):137-42. PubMed ID: 3896038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous naloxone administration in schizophrenia and affective illness.
    Davis GC; Bunney WE; DeFraites EG; Kleinman JE; van Kammen DP; Post RM; Wyatt RJ
    Science; 1977 Jul; 197(4298):74-7. PubMed ID: 325650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone in stroke: worth a trial?
    Perey L; Mosimann B; Buchser E; Carroll R; Friedli P; Enrico JF; Rüedi B
    Crit Care Med; 1984 Jul; 12(7):614. PubMed ID: 6734233
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of naloxone in neurology].
    Mendel T; Barańska-Gieruszczak M
    Neurol Neurochir Pol; 1988; 22(6):553-7. PubMed ID: 3077436
    [No Abstract]   [Full Text] [Related]  

  • 40. Naloxone in the treatment of stroke.
    Sugar O
    Surg Neurol; 1982 Sep; 18(3):225. PubMed ID: 7179078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.